Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.

Abstract:

AIM:Metastasis of unknown primary (MUP) is commonly treated with radiation therapy (RT) to the entire mucosal surfaces and bilateral neck nodes (LN). We report outcomes of oropharynx-targeted RT, retropharyngeal nodes (RPN) and bilateral LN in this context. PATIENTS AND METHODS:Single-Institution retrospective study of 68 patients. Forty percent were treated with intensity-modulated radiation therapy (IMRT). Fifty-six percent received concurrent chemoradiotherapy (CCRT). The median age was 58 years, 82% were Caucasian, and 75% males. Stage III disease was present in 9%, stage IVA in 75% and IVB in 16%. RESULTS:At a median follow-up of 3.5 years, the actuarial locoregional control was 95.5%. The emergence of primary developed in 1patient (1.5%) and 2patients (3%) failed in the neck. The median time-to-locoregional failure (LRF) was 18 months. Actuarial long-term RT toxicity was grade 1 xerostomia (68%), dysphagia (35%), neck stiffness (15%) and trismus (6%). CONCLUSION:RT to the oropharynx, RPN, and bilateral neck provides excellent oncological and functional outcomes in MUP in non-Asian patients. Sparing the mucosal surfaces of the nasopharynx, hypopharynx, and larynx seems reasonable without impacting on survival and locoregional control.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Mourad WF,Hu KS,Shasha D,Concert C,Ishihara D,Lin W,Shourbaji RA,Ryniak M,Gamez ME,Lukens JN,Li Z,Culliney BE,Khorsandi AS,Tran T,Jacobson A,Manolidis S,Schantz S,Urken M,Persky MS,Harrison LB

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

243-8

issue

1

eissn

0250-7005

issn

1791-7530

pii

34/1/243

journal_volume

34

pub_type

临床试验,杂志文章
  • Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.

    abstract:BACKGROUND:The description of the different forms of circulating PSA has opened a new strategy in the diagnosis of prostate cancer. The aim of our study was to assess the diagnostic potential of PSA and the PSA fractions in the diagnosis of benign prostate hyperplasia (BPH) and prostate cancer. PATIENTS AND METHODS:We...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Filella X,Alcover J,Corral JM,Molina R,Beardo P,Ballesta AM

    更新日期:2001-09-01 00:00:00

  • Adaptive Radiotherapy for Glioblastoma Multiforme - The Impact on Disease Outcome.

    abstract:BACKGROUND/AIM:To study the changes of glioblastoma multiforme during chemoradiotherapy (CRT) and to evaluate the impact of changes on dosimetry and clinical outcomes. PATIENTS AND METHODS:Forty-three patients underwent volumetric imaging-based replanning. Prognostic factors and gross tumor volume changes in relation ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14425

    authors: VÉgvÁry Z,DarÁzs B,Paczona V,Dobi Á,Reisz Z,Varga Z,Fodor E,CserhÁti A,OlÁh J,Kis D,BarzÓ P,HideghÉty K

    更新日期:2020-08-01 00:00:00

  • Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

    abstract:BACKGROUND:The prognostic significance of mutant p53 protein, p-glycoprotein (P-gp) and glutathione S-transferase-pi (GST-pi) in patients with unresectable non-small cell lung cancer (NSCLC) has not been established. MATERIALS AND METHODS:We performed immunohistochemical staining of p53, P-gp and GST-pi using transbro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Miyatake K,Gemba K,Ueoka H,Nishii K,Kiura K,Tabata M,Shibayama T,Takigawa N,Kawaraya M,Tanimoto M

    更新日期:2003-05-01 00:00:00

  • Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.

    abstract::Matrix metalloproteinase-7 (MMP-7), MMP-9, MMP-13, and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are considered to have important roles in the invasiveness and outcomes of colorectal cancer (CRC). This study examined the clinicopathological significance of the relative expression of these genes in patien...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yamada T,Oshima T,Yoshihara K,Tamura S,Kanazawa A,Inagaki D,Yamamoto N,Sato T,Fujii S,Numata K,Kunisaki C,Shiozawa M,Morinaga S,Akaike M,Rino Y,Tanaka K,Masuda M,Imada T

    更新日期:2010-07-01 00:00:00

  • Mutations of mitochondrial DNA as potential biomarkers in breast cancer.

    abstract:BACKGROUND:Alterations of mitochondrial DNA (mtDNA) have been found in cancer patients, therefore informative mtDNA mutations could serve as biomarkers for the disease. MATERIALS AND METHODS:The two hypervariable regions HVR1 and HVR2 in the D-Loop region were sequenced in ten paired tissue and plasma samples from bre...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cai FF,Kohler C,Zhang B,Chen WJ,Barekati Z,Garritsen HS,Lenner P,Toniolo P,Zhang JJ,Zhong XY

    更新日期:2011-12-01 00:00:00

  • Somatostatin controls LFA-1 gene expression by altering neuraminidase expression in spleen cells.

    abstract::This study investigated whether neuraminidase (Neu) affects LFA-1 mRNA expression in spleen cells and whether somatostatin (SOM) and substance P (SP) treatment induce changes in the Neu mRNA expression level in spleen cells. Neu treatments down-regulated the LFA-1 mRNA levels after culturing for 2 h. SOM increased the...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yoon WK,Kim HJ,Son HY,Jeong KS,Park SJ,Kim TH,Kim SH,Kim SR,Ryu SY

    更新日期:2004-07-01 00:00:00

  • Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World.

    abstract:AIM:This retrospective observational study evaluated the role of hypo-fractionated stereotactic radiotherapy (SRT) in patients with oligo-progressive metastatic renal cell carcinoma (mRCC) treated with first-line oral tyrosine kinase inhibitors (TKI). Data on local control, delay of further progression, and safety are ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14730

    authors: Gebbia V,Girlando A,DI Grazia A,Fazio I,Borsellino N,Piazza D,Serretta V,Pergolizzi S,Pontoriero A,Firenze A,Valerio MR

    更新日期:2020-12-01 00:00:00

  • High levels of Wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer.

    abstract:AIM:The aim of the present study was to evaluate the correlation between WT1 expression levels and clinical features, to investigate the prognostic value of WT1 expression and to use lentiviral constructs to examine whether overexpression of WT1 affects cell proliferation and invasion in ovarian cancer patients. MATER...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liu Z,Yamanouchi K,Ohtao T,Matsumura S,Seino M,Shridhar V,Takahashi T,Takahashi K,Kurachi H

    更新日期:2014-05-01 00:00:00

  • vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.

    abstract:BACKGROUND/AIM:The definition of vault (ribonucleoprotein particles) function remains highly complex. Vaults may cooperate with multidrug resistance (MDR) proteins, supporting their role in drug resistance. This topic is the main theme of this publication. MATERIALS AND METHODS:The cell viability was determined by an ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11656

    authors: Wojtowicz K,Januchowski R,Nowicki M,Zabel M

    更新日期:2017-06-01 00:00:00

  • Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents.

    abstract:BACKGROUND:Chkl is a checkpoint gene that is activated after DNA damage. It phosphorylates and inactivates Cdc25C at the late G2 phase. The inactivation of Cdc25C and consequently, the inactivation of Cdc2, are required for the G2 arrest induced by DNA damage. METHODS:We treated 184B5 cell line and its E6 transformed ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Luo Y,Rockow-Magnone SK,Joseph MK,Bradner J,Butler CC,Tahir SK,Han EK,Ng SC,Severin JM,Gubbins EJ,Reilly RM,Rueter A,Simmer RL,Holzman TF,Giranda VL

    更新日期:2001-01-01 00:00:00

  • Inhibition of phospholipase D by agents that inhibit cell growth.

    abstract::The phospholipases are an important class of enzymes for growth factor and oncogene intracellular signalling. The anti-tumor drug suramin was found to inhibit phosphatidylcholine hydrolysis and trans-phosphatidylation by solubilized rat brain phospholipase D (PLD) with an IC50 of 15 microM. An azo analogue of suramin,...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gratas C,Powis G

    更新日期:1993-07-01 00:00:00

  • Colorectal cancer: seed and soil hypothesis revisited.

    abstract::The local growth and metastatic potential of colorectal cancer is the outcome of a dynamic balance between cancer cells and the immune system, at both a local and systemic level, summarized as the "seed and soil" hypothesis. Until recently, the staging and treatment approaches for colorectal cancer appeared to be orie...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Seretis F,Seretis C,Youssef H,Chapman M

    更新日期:2014-05-01 00:00:00

  • In vivo model systems for assessing an anti-cancer drug: responses of autochthonous and transplanted prostate tumors to cyclophosphamide.

    abstract::Therapeutic effects of cyclophosphamide (CPA) were compared in L-W rats with (a) transplanted prostate adenocarcinomas (PAs), and (b) with induced autochthonous PAs. All rats, except controls, were treated by IP-administered CPA in slow-release silastic membranes (a) at time 0 after inoculation of transplanted PA cell...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pollard M,Luckert PH

    更新日期:1990-01-01 00:00:00

  • A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.

    abstract:BACKGROUND:Melanoma is among the top three cancers to present with brain metastasis. The risk of brain metastases in advanced melanoma increases with disease duration. Cytotoxic chemotherapy does not have a significant role in the management of melanoma patients with brain metastases, neither alone nor in conjunction w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11038

    authors: Basnet A,Saad N,Benjamin S

    更新日期:2016-09-01 00:00:00

  • Combined oral topotecan plus carboplatin in relapsed or advanced cervical cancer: a GINECO phase I-II trial.

    abstract:AIM:Combined cisplatin-topotecan therapy is standard care for advanced cervical cancer, however it is associated with haematotoxicity and nephrotoxicity. This trial was designed to assess the combination of carboplatin which is less nephrotoxic, and oral topotecan. PATIENTS AND METHODS:Patients with advanced/recurrent...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Kurtz JE,Freyer G,Joly F,Gladieff L,Kaminski MC,Fabbro M,Floquet A,Hardy-Bessard AC,Raban N,Ray-Coquard I,Pujade-Lauraine E,GINECO Group, France.

    更新日期:2012-03-01 00:00:00

  • Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.

    abstract:BACKGROUND/AIM:Glioblastoma multiforme (GBM) is a malignant primary brain tumor with high rates of recurrence. This study aimed to investigate the effect of repurposed drug combinations on GBM. MATERIALS AND METHODS:Viability of U87 MG and 11ST patient-derived GMB cell lines, after valproic acid, tranylcypromine or ri...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13099

    authors: Sachkova A,Sperling S,Mielke D,Schatlo B,Rohde V,Ninkovic M

    更新日期:2019-01-01 00:00:00

  • A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib.

    abstract:BACKGROUND:Sunitinib is a tyrosine kinase inhibitor (TKI) targeting tumour angiogenesis in patients with advanced renal cell carcinoma (RCC). Currently no universally agreed model exists correlating the expression of angiogenesis markers with the success of treatment. PATIENTS AND METHODS:We retrospectively analysed a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11315

    authors: Stubbs C,Bardoli AD,Afshar M,Pirrie S,Miscoria M,Wheeley I,Porfiri E

    更新日期:2017-01-01 00:00:00

  • Differentiation can convey resistance to transformation by activated ras oncogene.

    abstract::Nonterminal cellular differentiation has recently been shown to induce transformed cells to revert to a benign state and to become resistant to retransformation by chemical and physical carcinogens without limiting their proliferative potential. Nonterminal differentiation also induces native 3T3 T mesenchymal stem ce...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tzen CY,Maercklein PB,Scott RE

    更新日期:1990-09-01 00:00:00

  • Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.

    abstract:BACKGROUND:Trastuzumab has no major side-effects except the potential for cardiac toxicity. The main objective of this study was to evaluate the association between trastuzumab-associated cardiac toxicity and two potential risk factors: alcohol intake and HER2 polymorphisms. PATIENTS AND METHODS:In a retrospective coh...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lemieux J,Diorio C,Côté MA,Provencher L,Barabé F,Jacob S,St-Pierre C,Demers E,Tremblay-Lemay R,Nadeau-Larochelle C,Michaud A,Laflamme C

    更新日期:2013-06-01 00:00:00

  • Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.

    abstract:BACKGROUND:Despite receiving post-operative 5-fluorouracil (5-FU)-based chemotherapy, approximately 50% of patients with stage IIIC colon cancer experience recurrence. Currently, no molecular signature can predict response to 5-FU. MATERIALS AND METHODS:Mouse models of colon cancer have been developed and characterize...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hadac JN,Miller DD,Grimes IC,Clipson L,Newton MA,Schelman WR,Halberg RB

    更新日期:2016-03-01 00:00:00

  • An Adult Patient With Rare Primary Intracranial Alveolar Rhabdomyosarcoma.

    abstract::We report a rare case of primary intracranial alveolar rhabdomyosarcoma (ARMS) in the right temporal lobe of a 51-year-old male. ARMS is one of 3 histological subtypes of rhabdomyosarcoma that most commonly presents in older children and younger adults. To our knowledge, there have been no prior published reports of p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13441

    authors: Desai KB,Mella D,Pan E

    更新日期:2019-06-01 00:00:00

  • Regulation and turnover of cellular retinol-binding protein in a xenografted human ovarian tumour.

    abstract::A human ovarian mesodermal mixed heterologous carcinoma, with a high content of cellular retinol-binding protein (CRBP), was used to study the effects of retinoid and hormonal treatment on tumour CRBP content, tumour growth rate, differentiation and turnover of CRBP. Tumour growth in general was accompanied by an incr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wahlberg P,Fex G,Wennerberg J,Willén R

    更新日期:1989-01-01 00:00:00

  • Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.

    abstract::We carried out a systematic review of new drugs active in non-small cell lung carcinoma (NSCLC). Fifty five phase II and III trials were reviewed (vinorelbine (19 trials), paclitaxel (15), gemcitabine (11), docetaxel (6), topotecan (2) or irinotecan (2)). The first four ones could be considered as active drugs when gi...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Meert AP,Berghmans T,Branle F,Lemaître F,Mascaux C,Rubesova E,Vermylen P,Paesmans M,Sculier JP

    更新日期:1999-09-01 00:00:00

  • Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR.

    abstract:BACKGROUND/AIM:Omega 3 polyunsaturated fatty acids (PUFAs) have been shown to inhibit the induction and progression of many tumor types. The aim of this study was to determine the anticancer effect of docosahexaenoic acid monoglyceride (MAG-DHA) alone and in combination with the chemotherapeutic agent carboplatin (CBT)...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12048

    authors: Morin C,Fortin S

    更新日期:2017-11-01 00:00:00

  • Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells.

    abstract:BACKGROUND/AIM:Bevacizumab (BV) has been used for the treatment of recurrent glioblastoma. However, it also induces epithelial-mesenchymal transition (EMT) in glioblastoma cells, which compromises its efficacy. BATF2 (basic leucine zipper ATF-like transcription factor 2), a multi-target transcriptional repressor, has b...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11821

    authors: Huang W,Zhang C,Cui M,Niu J,Ding W

    更新日期:2017-08-01 00:00:00

  • Role of chemotherapeutic antagonism in opportunistic infections.

    abstract::The most widely-known anti-tumor drugs often induce marked immunosuppression which can give rise to one or more sepses. Anti-infection measures immediately applied can sometimes prove largely ineffective or even useless, the patient dying not as a result of the spread of the tumour but as a direct consequence of oppor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Castelli M,Baggio G,Ruberto AI,Malagoli M,Casolari C,Rossi T,Galatulas I

    更新日期:1997-11-01 00:00:00

  • Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.

    abstract::Oral squamous cell carcinomas overexpress tumor-associated antigens, yet these antigens do not induce an immune-mediated anti-tumor response. The absence of an anti-tumor immune response may be due to poor immunogenicity of the tumor antigens or due to presence of factors that restrict immune functions. We have analyz...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ravindranath NM,Nishimoto K,Chu K,Shuler C

    更新日期:2000-01-01 00:00:00

  • Inhibition of tubulin polymerization in megakaryocyte cell lines leads to polyploidization which affects the metabolism of actin.

    abstract::Megakaryocyte polyploidization responds to platelet demand and results from the lack of cytoplasmic separation while the nucleus keeps dividing. In normal telophase, the plane of the actin constriction ring is determined by the tubulin spindle. In order to investigate the role of tubulin in the megakaryocyte polyploid...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Baatout S,Chatelain B,Staquet P,Symann M,Chatelain C

    更新日期:1998-05-01 00:00:00

  • Expression of E-cadherin and catenins in invasive mammary carcinomas.

    abstract::E-Cadherin has been shown to be an invasion tumor suppressor gene, but few epidemiological studies have revealed relationships between loss of E-cadherin expression and invasive tumor growth and/or metastasis. The adhesive function of E-cadherin is dependent on the integrity of the catenin components which link E-cadh...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zschiesche W,Schönborn I,Behrens J,Herrenknecht K,Hartveit F,Lilleng P,Birchmeier W

    更新日期:1997-01-01 00:00:00

  • Immunohistochemical characterization of tumor liberated particles (TLP) expression pattern in lung cancer.

    abstract::The role of serum tumor markers in lung cancer has not been defined. It is widely believed that almost all neoplasms produce at least a few substances, but the identity of most of the known substances has not been correlated with a positive role in either the diagnosis or prognosis of patients with these neoplasms. We...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tarro G,Esposito C,Perna A,Claudio PP,Giordano A

    更新日期:1998-07-01 00:00:00